[go: up one dir, main page]

AU2011243597A1 - Novel hydroxamic acid derivative - Google Patents

Novel hydroxamic acid derivative

Info

Publication number
AU2011243597A1
AU2011243597A1 AU2011243597A AU2011243597A AU2011243597A1 AU 2011243597 A1 AU2011243597 A1 AU 2011243597A1 AU 2011243597 A AU2011243597 A AU 2011243597A AU 2011243597 A AU2011243597 A AU 2011243597A AU 2011243597 A1 AU2011243597 A1 AU 2011243597A1
Authority
AU
Australia
Prior art keywords
acid derivative
hydroxamic acid
novel hydroxamic
novel
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2011243597A
Other versions
AU2011243597B2 (en
Inventor
Yasuko Kawaguchi
Hironori Kotsubo
Yusuke Oka
Muneo Shoji
Yoichiro Suga
Masato Takahashi
Hajime Takashima
Risa Tsuruta
Fumito Uneuchi
Hiroki Urabe
Tetsuya Yabuuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Taisho Pharmaceutical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd, Taisho Pharmaceutical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority claimed from PCT/JP2011/059737 external-priority patent/WO2011132712A1/en
Publication of AU2011243597A1 publication Critical patent/AU2011243597A1/en
Application granted granted Critical
Publication of AU2011243597B2 publication Critical patent/AU2011243597B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2011243597A 2010-04-20 2011-04-20 Novel hydroxamic acid derivative Ceased AU2011243597B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010-096852 2010-04-20
JP2010096852 2010-04-20
PCT/JP2011/059737 WO2011132712A1 (en) 2010-04-20 2011-04-20 Novel hydroxamic acid derivative

Publications (2)

Publication Number Publication Date
AU2011243597A1 true AU2011243597A1 (en) 2012-11-22
AU2011243597B2 AU2011243597B2 (en) 2014-05-08

Family

ID=44834229

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011243597A Ceased AU2011243597B2 (en) 2010-04-20 2011-04-20 Novel hydroxamic acid derivative

Country Status (27)

Country Link
US (2) US9073821B2 (en)
EP (1) EP2562155B8 (en)
JP (1) JP5763621B2 (en)
KR (1) KR101826371B1 (en)
CN (1) CN103003233B (en)
AU (1) AU2011243597B2 (en)
BR (1) BR112012026926B1 (en)
CA (1) CA2796750C (en)
CY (1) CY1121761T1 (en)
DK (1) DK2562155T3 (en)
ES (1) ES2738148T3 (en)
HR (1) HRP20191381T1 (en)
HU (1) HUE044575T2 (en)
IL (1) IL222548A (en)
LT (1) LT2562155T (en)
MX (1) MX2012012227A (en)
NZ (1) NZ603198A (en)
PH (1) PH12012502087A1 (en)
PL (1) PL2562155T3 (en)
PT (1) PT2562155T (en)
RS (1) RS59255B1 (en)
SG (1) SG184958A1 (en)
SI (1) SI2562155T1 (en)
SM (1) SMT201900482T1 (en)
TR (1) TR201908891T4 (en)
TW (2) TWI543961B (en)
WO (1) WO2011132712A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201716375A (en) 2007-06-12 2017-05-16 Achaogen Inc Antibacterial agents
US9738604B2 (en) 2010-09-03 2017-08-22 Duke University Ethynylbenzene derivatives
AR083760A1 (en) * 2010-11-10 2013-03-20 Achaogen Inc ANTIBACTERIAL AGENTS AND PHARMACEUTICAL COMPOSITIONS
JP6006609B2 (en) * 2011-10-19 2016-10-12 大正製薬株式会社 Pharmaceuticals containing novel hydroxamic acid derivatives
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
CN103980175B (en) * 2013-02-07 2016-06-01 山东威智医药工业有限公司 Prepare the method for vildagliptin
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
PT2975022T (en) 2013-03-15 2019-06-11 Fujifilm Toyama Chemical Co Ltd Novel hydroxamic acid derivative or salt thereof
US9908851B2 (en) 2013-08-16 2018-03-06 Duke University 2-piperidinyl substituted N,3-dihydroxybutanamides
JP6458270B2 (en) * 2013-08-16 2019-01-30 デューク ユニバーシティ Substituted hydroxamic acid compounds
US10189786B2 (en) 2013-08-16 2019-01-29 Duke University Antibacterial compounds
JP2016210682A (en) * 2013-10-18 2016-12-15 大正製薬株式会社 Hydroxamic acid derivative
WO2015056799A1 (en) * 2013-10-18 2015-04-23 大正製薬株式会社 Hydroxamic acid derivative
JP2016210683A (en) * 2013-10-18 2016-12-15 大正製薬株式会社 Hydroxamic acid derivative
WO2016039433A1 (en) 2014-09-12 2016-03-17 富山化学工業株式会社 Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
CA2960936A1 (en) * 2014-09-12 2016-03-17 Toyama Chemical Co., Ltd. Method for using novel hydroxamic acid derivative and antibacterial substance in combination
JP6377676B2 (en) * 2015-06-30 2018-08-22 富山化学工業株式会社 Process for producing novel hydroxamic acid derivatives
CN109415302A (en) * 2016-03-31 2019-03-01 富士胶片富山化学株式会社 The crystal of new hydroxamic acid derivs, its manufacturing method and medicinal composition
ES2961564T3 (en) * 2016-04-25 2024-03-12 Univ Duke Benzoylglycine derivatives and methods of preparation and use thereof
WO2017223349A1 (en) 2016-06-23 2017-12-28 Achaogen, Inc. Antibacterial agents
US20190282500A1 (en) 2016-09-09 2019-09-19 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
AU2017325863B2 (en) * 2016-09-16 2021-08-19 Entasis Therapeutics Limited Beta-lactamase inhibitor compounds
MX390157B (en) 2016-12-23 2025-03-20 Intervet Int Bv COMPOUNDS FOR THE TREATMENT OF BOVINE OR SWINE RESPIRATORY DISEASE.
MX388647B (en) * 2016-12-23 2025-03-20 Intervet Int Bv COMPOUNDS USEFUL FOR THE TREATMENT OF INFECTION CAUSED BY MANNHEIMIA HAEMOLYTICA OR HISTOPHILUS SOMNI.
US20200062789A1 (en) 2017-01-31 2020-02-27 Fujifilm Toyama Chemical Co., Ltd. Hydroxamic acid prodrug compound or salt thereof, lyophilized formulation, lpxc inhibitor, and antibacterial agent
US10085999B1 (en) 2017-05-10 2018-10-02 Arixa Pharmaceuticals, Inc. Beta-lactamase inhibitors and uses thereof
US10280161B2 (en) 2017-10-02 2019-05-07 Arixa Pharmaceuticals, Inc. Aztreonam derivatives and uses thereof
CA3090833A1 (en) * 2018-02-10 2019-08-15 Kbp Biosciences Co., Ltd. Compound acting as antibiotics
WO2020002238A1 (en) * 2018-06-25 2020-01-02 Intervet International B.V. Compounds for the treatment of bovine or swine respiratory disease
US11180500B2 (en) 2018-10-01 2021-11-23 Arixa Pharmaceuticals, Inc. Derivatives of relebactam and uses thereof
TW202039478A (en) * 2018-11-21 2020-11-01 日商大正製藥股份有限公司 Novel imidazole derivative
CN109400608B (en) * 2018-12-15 2021-08-31 西南大学 Preparation and application of diazaspiro[4,5]decane tartaric acid derivatives
EP3938366A1 (en) 2019-03-12 2022-01-19 Arixa Pharmaceuticals, Inc. Crystalline form of an avibactam derivative
WO2020219258A1 (en) 2019-04-25 2020-10-29 Arixa Pharmaceuticals, Inc. Methods of synthesizing aztreonam derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4180900A (en) * 1999-04-02 2000-10-23 Du Pont Pharmaceuticals Company Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase
EA007649B1 (en) * 1999-09-08 2006-12-29 Слоан-Кеттеринг Инститьют Фор Кэнсер Рисёч Histone deacetylase inhibitors causing cells differentiating
WO2002030873A1 (en) * 2000-10-10 2002-04-18 Fujisawa Pharmaceutical Co., Ltd. Mmp inhibitor
JP4601053B2 (en) 2002-12-24 2010-12-22 第一三共株式会社 New ethylenediamine derivatives
EA011808B1 (en) 2003-01-08 2009-06-30 Новартис Вэксинес Энд Дайэгностикс, Инк. Antibacterial agents
CN101010298A (en) * 2004-04-05 2007-08-01 默克Hdac研究有限责任公司 Histone deacetylase inhibitor prodrugs
US20070066646A1 (en) * 2005-08-02 2007-03-22 Genmedica Therapeutics Sl Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof
JP2009520695A (en) 2005-12-15 2009-05-28 ヴィキュロン ファーマシューティカルズ インコーポレイテッド N-hydroxyamide derivative having antibacterial activity
US20080085893A1 (en) * 2006-10-06 2008-04-10 Shyh-Ming Yang Matrix metalloprotease inhibitors
TW201716375A (en) 2007-06-12 2017-05-16 Achaogen Inc Antibacterial agents
WO2009007814A1 (en) 2007-07-11 2009-01-15 Pfizer Inc. Inhibitors of carbonic anhydrase
EP2315746A1 (en) 2008-08-04 2011-05-04 Schering Corporation Urea derivatives as antibacterial agents
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
EP2334636A2 (en) * 2008-09-19 2011-06-22 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
US20100135960A1 (en) 2008-11-18 2010-06-03 Yat Sun Or Antiviral acylsulfonamide derivatives
WO2011005355A1 (en) 2009-05-07 2011-01-13 Achaogen, Inc. Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria

Similar Documents

Publication Publication Date Title
EP2562155B8 (en) Hydroxamic acid derivative
AU2011243597A1 (en) Novel hydroxamic acid derivative
AU2010100385A4 (en) Eldeap
EP2634171B8 (en) 23-yne-vitamin d3 derivative
AU2010101325A4 (en) MobileVBM
AU2010101195A4 (en) Vehiclecctv
AU2010101200A4 (en) Ileo-alert
AU2010100344A4 (en) Icbd
AU2010101315A4 (en) AcroSafe
AU2010100625A4 (en) TreeCups
AU2010100716A4 (en) Whatsthatbillboard
AU2010100523A4 (en) Brakebuddy
AU2010901925A0 (en) Improved oligothiophenes
HK1182380A (en) Novel processes
HK1180977A (en) Derivatives of 1-amino-2-cyclopropylethylboronic acid
AU2010900285A0 (en) Sparger
HK1182771A (en) Compound
AU2010901269A0 (en) Knoggin mate
AU2010904641A0 (en) Improved horseshoe
AU2010900814A0 (en) Skrinart
AU2010900793A0 (en) Solsaver
AU2010901164A0 (en) Fonetrak/Fonebill
AU2010901621A0 (en) Ecoglowstick
AU2010901745A0 (en) Computerforvariableresistancedevice
AU2010901040A0 (en) eRaffle